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SUMMARY
By controlling the transmission of Chagas disease, the challenge of providing assistance to millions of infected patients that reach 
old age arises. In this study, the socioeconomic, demographic and comorbidity records of all elderly chagasic patients followed at 
the Pharmaceutical Care Service of the Chagas Disease Research Laboratory were assessed. The information related to the clinical 
form of the disease was obtained from medical records provided by the Walter Cantídio University Hospital. The profile of the 
studied population was: women (50.5%); mean age of 67 years; retired (54.6%); married (51.6 %); high illiteracy rate (40.2%); and 
family income equal to the minimum wage (51.5%). The predominant clinical forms of Chagas disease were cardiac (65.3%) and 
indeterminate (14.7%). The main electrocardiographic changes were the right bundle branch block (41.0%), associated or not with 
the anterosuperior left bundle branch block (27.4%). The average number of comorbidities per patient was 2.23 ± 1.54, with systemic 
arterial hypertension being the main one found (67.0%). It was found that the elderly comprise a vulnerable group of patients that 
associate aging with cardiac and/or digestive disorders resulting from the evolution of Chagas disease and other comorbidities, which 
requires special attention from health services to ensure more appropriate medical and social care.
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INTRODUCTION
Chagas disease (CD) is a chronic infection caused by the protozoan 
Trypanosoma cruzi and transmitted to humans by blood-sucking insects 
(kissing bugs) of the family Reduviidae and subfamily Triatominae30,47. 
As a result of the success achieved in the efforts to control vectorial 
and transfusional transmissions of CD during the last decades, the 
challenge of providing assistance to millions of infected in its chronic 
phase arises59. It is estimated that about 18 million people are infected 
with the disease, particularly in Latin America, with about 21,000 deaths 
reported each year63.
Several studies have demonstrated a progressive reduction of 
seropositivity for CD in young age groups and the consequent increase 
of the prevalence of infection among older individuals3,6,34. It is believed 
that a large proportion of individuals with CD are either already in old 
age, or will become elderly in the near future21.
It is essential that importance be given to the association between CD 
and the aging process of its carriers. Along with the decline that occurs 
with advancing age21, added to cardiac and/or digestive disorders that 
result from the progression of CD, this group of patients is susceptible 
to other chronic diseases of advanced age, such as ischemic heart 
disease, diabetes mellitus, hypertension and arthrosis41. This increases 
the morbidity and worsens the quality of life of the individuals that age 
in this unfavorable condition3,31,38,64. 
These associations lead to a significant demand for health services 
and drugs, predisposing this vulnerable population to many risks such as 
polypharmacy21,43,60. The scarcity of research on CD among the elderly 
contrasts with the importance of this disease in this age group34.
Therefore, the aim of this study was to better understand the 
clinical and epidemiological profile of elderly chagasic patients from 
a Pharmaceutical Care Service reference in the State of Ceará, since 
these aspects of this population in particular should receive attention, 
given that medical and social care is one of the main challenges of this 
neglected disease in Brazil3,15.
MATERIAL AND METHODS
This was a descriptive cross-sectional survey conducted in the 
Pharmaceutical Care Service on the chagasic patients of the Laboratory 
of Research in CD at the Federal University of Ceará (LPDC/UFC). This 
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service is linked to the Cardiology Outpatient Unit of the Walter Cantídio 
University Hospital (HUWC), responsible for the clinical diagnosis of 
patients with CD. Once diagnosed, the patient is referred to this Service 
to perform the drug treatment for CD.
The records of all patients followed in the Service during the period 
of July 2005 (date of commencement of this Service) to June 2013 were 
analyzed, totaling eight years. The study included elderly patients of 
both sexes selected according to the criteria of the Brazilian Institute 
of Geography and Statistics (IBGE), which sets the age as 60 years or 
over29. Patients whose medical records were not available for consultation 
at HUWC or presented insufficient data for the proposed objectives and 
analyses were excluded from the clinical evaluation of the study.
The following variables: gender, age, occupation, marital status, 
education, family income, place of origin, comorbidities, medication 
use and symptoms related to CD, were obtained from records filed 
in the LPDC obtained by interview during the first contact with the 
patient on the Service. The clinical information related to CD, the 
records of radiological studies of the esophagus, colon and heart, and 
electrocardiographic results were obtained through medical records filed 
in the HUWC.
To characterize the clinical form of the disease, the following criteria 
were used in accordance with the literature6,11:
I - Cardiac form: Symptomatic or asymptomatic individuals with 
electrocardiographic (ECG) changes suggestive of cardiac involvement 
and/or registration of cardiomegaly (detected by chest X-ray) in the 
medical record; 
II - Digestive form: Individuals with test results in their medical 
records (esophagogram or endoscopy and/or barium enema or 
colonoscopy) compatible with megaesophagus and/or megacolon, and/
or history of surgery for megaesophagus and/or megacolon. 
III - Indeterminate form: Asymptomatic individuals presenting 
normal electrocardiogram (ECG), without registration of cardiomegaly 
in the medical records, and no changes in X-ray compatible with 
megaesophagus and/or megacolon; 
IV - Mixed Form: Individuals presenting association between cardiac 
and digestive form.
This study was approved by the Research Ethics Committee of the 
HUWC in June 2012 under protocol number 031.05.12. 
For statistical analysis, the GraphPad Prism Program (version 6.0) 
was used. For values with normal distribution, the “t” Student test was 
used, whereas the Mann Whitney test was used for values that did not 
show normal distribution. To investigate possible associations between 
variables, the Fisher’s exact test was used. A significance level of p < 
0.05 was adopted.
RESULTS
From the total of 411 patients followed at this Service between July 
2005 and June 2013, 97 (23.6%) were individuals aged over 60 years. 
A progressive increase in the percentage of elderly patients relative 
to the total number of patients enrolled in the Service has been observed 
during its eight years of activity. Between July 2005 and June 2007, only 
two elderly patients were registered among 59 patients (3.4%). In the 
period from July 2007 to June 2009, there were 16 elderly patients from 
a total of 80 patients (20.0%). In the following period, July 2009 to June 
2011, 105 patients were enrolled, 22 of whom were elderly (21.0%). And 
finally between July 2011 and June 2013, 167 patients were registered and 
57 were elderly (34.1%) (Fig. 1). Comparing the percentage of elderly 
patients corresponding to the first four years of activity of the service 
(12.9%) with the subsequent four years (29.0%), there was a significant 
increase in this percentage (p = 0.003).
Regarding the sociodemographic characteristics, it was found that 
most patients were women (50.5%); 70.1% were aged between 60 and 
69 years; the mean age was 66.9 ± 6.5 years; 54.6 % were retired, and 
among those still working, the main occupation registered was farming 
(55.0 %); 49.5% had not finished elementary school and a high percentage 
of illiteracy was found (40.2 %); 51.5% had a monthly income equal to 
the minimum wage; and most (51.6 %) were married .
With respect to the place of origin, 81 patients (83.5%) were reported 
to reside in the countryside of the state of Ceará and 16 (16.5%) were 
from the capital, Fortaleza. The main inland towns cited by the patients 
as places of origin were: Quixeré (18;18.5%), Jaguaruana (16;16.5%), 
Russas (14;14.4%) and Limoeiro do Norte (13;13.4%), municipalities 
located in the Low Jaguaribe Microregion, in Jaguaribe Valley. The other 
cities mentioned by patients as places of residence are shown in Figure 2.
When asked how they were diagnosed with CD, the majority of 
patients (30.9%) reported that the presentation of symptoms of the 
cardiac and/or digestive form led them to seek medical care; 27.8% were 
diagnosed by routine serological tests; 19.6% by electrocardiographic 
changes characteristic of CD; and 6.2% through blood donation. 
 In terms of symptoms related to CD, 18.5% of patients reported being 
asymptomatic, while 81.5% reported at least one symptom attributable 
to CD. The most frequently reported cardiac symptoms were chest 
pain (42.3%), dyspnea (36.1%), palpitations (23.7%), fatigue (17.5%), 
dizziness (7.2%) and syncope (6.2%). The most cited digestive symptoms 
were constipation (36.1%) and dysphagia (23.7%).
Two patients were excluded from the evaluation of the clinical form 
of CD due to insufficient information in their medical records (loss of 
Fig. 1 - Biannual increase of the percentage of elderly patients with Chagas disease enrolled 
in the Pharmaceutical Care Service in Ceará State during its eight years of activity (n = 97).
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2.1%). Thus, the 95 analyzed patients had the following distribution 
according to the clinical form: predominance of the cardiac form (65.3%), 
followed by indeterminate form (14.7%), mixed (13.7%) and digestive 
(6.3%) (Fig. 3). 
Among patients with the mixed form, the association between 
cardiac form and chagasic megacolon (61.5%) was dominant, followed 
by cardiac form in association with megaesophagus (30.8%). One patient 
(7.7%) presented the cardiac form associated with both megacolon 
and megaesophagus. As for those ranked in the digestive form, four 
patients (66.7%) suffered from megacolon while two (33.3%) had 
megaesophagus.
Among these 95 patients, 75 (77.3%) had at least one change in ECG 
characteristics of CD. The major electrocardiographic abnormalities 
found among elderly patients with the isolated cardiac form of CD or 
associated with the digestive form (mixed form) are described in Table 1.
With regard to the existence of other diseases associated with CD, 
only 13.4% of patients reported no comorbidities, while 86.6% reported 
having at least one concomitant disease to CD. The average number of 
comorbidities per elderly patient in this study was 2.23 ± 1.54 (CI: 1.92-
2.54) and the main ones reported are described in Table 2. In relation 
to changes possibly resulting from the evolution of CD, 12.4% of the 
followed patients had arrhythmia and 8.2% congestive heart failure 
(CHF).
With respect to medication use, 84.5% of the subjects reported 
continuous use of at least one drug. The average number of medications 
per patient was 3.12 ± 2.44 (CI: 2.63-3.61). The therapeutic agents most 
frequently used were diuretics (45.4%), angiotensin-converting enzyme 
inhibitors (ACEI) (36.1%), α and β-blockers (21.6%), anticoagulants 
Fig. 2 - Place of origin of the elderly patients with Chagas disease in the state of Ceará (n = 97).
Fig. 3 - Clinical forms of the Chagas disease of elderly patients followed at the Pharmaceutical 
Care Service in Ceará State (n = 95).
Table 2 
Comorbidities associated with Chagas disease in elderly patients followed in 
the Pharmaceutical Care Service in Ceará State (n = 97)
Comorbidities n %
Systemic Arterial Hypertension (SAH) 65 67.0
Dyslipidemia 31 31.9
Dyspepsia 16 16.5
Diabetes Mellitus 14 14.4
Osteoporosis 11 11.3
Depression 06 6.2
Arthritis 06 6.2
Ischemic Heart Disease 04 4.1
Asthma 04 4.1
Rheumatism 04 4.1
Hypothyroidism 03 3.1
Cerebrovascular Accident (CVA) 03 3.1
Chronic Renal Failure (CRF) 03 3.1
Table 1 
Electrocardiographic changes found in elderly patients with Chagas disease 
followed at the Pharmaceutical Care Service in Ceará State (n = 95)
Electrocardiographic changes n %
Right bundle branch block (RBBB) 39 41.0
Anterosuperior left bundle branch block (ASDB) 26 27.4
Changes in ventricular repolarization (CVR) 16 16.8
Ventricular extrasystole (VES) 13 13.9
Low voltage of the limb leads (LVLL) 06 6.3
First-degree atrioventricular block (AVB) 05 5.3
Sinus bradycardia 05 5.3
Electrically inactive area (EIA) 04 4.2
Left bundle branch block (LBBB) 03 3.2
Atrial fibrillation (AF) 03 3.2
Left ventricular hypertrophy (LVH) 03 3.2
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(21.6%), statins (17.5%), antacids/anti-ulcer (16.5%), anxiolytic/sedative 
(15.5%), antagonists of the angiotensin receptor 1 (14.4%), antidiabetic 
agents (13.4%), antiarrhythmic drugs (12.4%), calcium channel blockers 
(10.3%), laxatives (8.2%), drugs to treat osteoporosis (8.2%) and positive 
inotropic agents (7.2%).
DISCUSSION
The present study demonstrated a significant increase in the 
number of elderly patients enrolled in the Pharmaceutical Care Service 
throughout its eight years of activity. This finding corroborates the 
study of GUARIENTO et al.22, which showed a progressive increase in 
the percentage of elderly patients enrolled in the Outpatient Unit of the 
Group for Studies into Chagas Disease (GEDoCh) at the Clinical Hospital 
of Campinas State University (UNICAMP) over 25 years (1980-2005).
The increased prevalence of CD among individuals with older age can 
be attributed to: the reduction in the incidence of this disease in Brazil, 
resulting from the success of the vector and transfusion transmission 
control campaigns; the improving social status of the population with 
housing improvement in endemic regions; and greater efficiency in 
diagnostic and therapeutic approaches16,21,62. Furthermore, the Brazilian 
population in general has experienced major changes in its demographic 
profile with substantial aging of the population as a result of the fall in 
the rate of mortality associated with the rapid and marked decline of the 
fecundity rate28.
The rise of an elderly population with CD deserves special attention, 
since this association may have particularities that need further 
investigation9, making the studies regarding the clinical aspects of CD 
in this geriatric age group a priority15. Due to the fact that the elderly 
population has specific and peculiar characteristics, the healthcare for 
this group of patients requires a more careful evaluation from health 
professionals51, so that a clinical diagnosis of CD in the elderly is not 
confused with other diseases most prevalent in these individuals, such as 
dilated cardiomyopathy, ischemic heart disease, heart disease by arterial 
hypertension and cancer of the esophagus9.
This study allowed the identification of a sociodemographic standard 
for chagasic elderly patients followed in the Pharmaceutical Care Service. 
The following groups were predominant in the population: women, 
patients between 60 and 69 years old, retirees, married individuals, 
and those with a poor education and low income. A very similar profile 
was observed by ALVES et al.4 when 90 elderly chagasic patients from 
the Outpatient Clinic GEDoCh of the Hospital of UNICAMP were 
evaluated. It is known that the epidemiological profile of a patient 
with CD is that of an adult, from a rural region and with a low level 
of schooling, demonstrating the close relationship of the disease with 
underdevelopment and poverty14.
It is important to emphasize the high percentage (40.2%) of illiterate 
patients that were detected in this study. ALVES et al.4 reported in their 
study that this reality is a reflection of the socioeconomic conditions 
of chagasic patients who have few social opportunities, low wages and 
limited education.
Despite the small difference, the percentage of elderly chagasic 
women (50.5%) was higher than the percentage of men (49.5%) in the 
present study. In other studies, also involving elderly patients, the female 
sex was predominant compared to the male sex3,4,22. GUARIENTO et 
al.22 point out that this aspect may be related to worse prognosis of CD 
associated with the male sex. This fact is well evidenced in the literature, 
where the male sex acts as a risk factor for worse outcomes among chronic 
carriers of this disease so that men tend to die younger, not reaching 
old age49,52. Furthermore, a study showing the situation of the elderly 
in Brazil documented a higher mortality of men in relation to women35. 
This is what the literature on gerontology refers to as the feminization 
of aging, a result of increased life expectancy among women at 60, 70 
and 80 years old32,48.
Regarding the place of origin, it was observed that most of the 
elderly patients (67.0%) were from the Low Jaguaribe Microregion. The 
Jaguaribe Valley is a region in Ceará that has always aroused interest 
among researchers as to the epidemiological importance of CD. The 
pioneering studies were performed by ALENCAR2 and demonstrated 
high rates of human infection and capture of triatomines in this region. 
More recent studies have focused on the detection of seroprevalence in 
municipalities of the Lower Juaguaribe Microregion such as Limoeiro do 
Norte18, Jaguaruana6 and Russas13. According to BORGES-PEREIRA et 
al.6, from the literature about CD in Ceará, the municipality of Jaguaruana 
and neighboring regions have always been in the group of areas with 
the highest prevalence of T. cruzi infection. These same authors found 
that 52.9% of the seropositive patients for CD were over 50 years old 
and there were no individuals younger than 16 years old. This reduction 
of seropositivity in younger age groups and the consequent increase in 
the prevalence of the disease among older individuals is a result of the 
success of measures to control vectorial transmission. Thus, the active 
search in this region has led to the diagnosis of patients with CD mainly 
in the elderly age group, which is possibly a result of vectorial infection 
acquired in the past. Once diagnosed, these patients are referred to 
reference services in Fortaleza, including the Pharmaceutical Care 
Service of patients with CD of the LPDC, a fact that may explain the 
high prevalence of elderly patients from this region. 
The predominant clinical form of CD among patients included in this 
study was the cardiac, followed by the indeterminate, mixed and digestive 
forms. For mixed and digestive forms, the incidence of megacolon was 
higher than that of megaesophagus. These findings are consistent with 
other studies in the literature, where the cardiac form is prevalent among 
the elderly chagasic3,4,22.
The high percentage of cardiac form found in this study (65.3%) 
can be explained because it was performed with patients aged over 60 
years. Such an interpretation is associated with the fact that an older 
age is related to a more severe clinical form of CD with impairment 
of cardiac function21. This phenomenon has been documented in the 
literature, showing that the evolutionary character of CD reflects the 
progressive aging of its carriers, as the disease transmission has been 
interrupted16.
SILVA et al.58 have shown that the age variable acts as a risk factor 
associated with the development of Chagas heart disease. They observed 
that patients over 60 years old were three times more likely to have heart 
disease when compared to those aged 50-59 (OR = 2.89, 95% CI = 
1.09-7.61). This finding seems plausible, since the rate of conversion of 
chronic indeterminate to cardiac form, although small, is time dependent.
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According to PIANCASTELI50, the true prevalence of the digestive 
form is not well known or may be underestimated due to the greater 
propaedeutic difficulty and, in the case of colonopathy, to the lack of 
consensus on the interpretation of results. Moreover, it is important to 
mention that patients included in this study come from the Cardiology 
Clinic of the HUWC and are not always followed by a gastroenterologist, 
which may lead to an underestimation of the actual percentage of patients 
with the digestive form of the disease.
The patients classified as indeterminate (14.7%) constitute a group 
characterized by a long asymptomatic period (which may last a lifetime), 
with no clinical, electrocardiographic and radiological manifestations, 
and their diagnosis is based on positive serology and/or parasitology11,12. 
In most cases, chagasic individuals with this clinical form are unaware 
of the presence of infection and show good prognosis in the medium 
and long terms. However, they must still be regularly monitored, since 
about 2-5% of these patients annually advance to the cardiac and/or 
gastrointestinal forms39.
The pathogenesis of Chagas heart disease involves mechanisms 
such as direct injury caused by T. cruzi; autoimmunity induced by T. 
cruzi antigens, with consequent destruction of myocytes, sympathetic 
and parasympathetic ganglia; microvascular disease and neurogenic 
mechanisms with sympathetic and parasympathetic dysfunction, 
inducing the inflammatory process and fibrosis26. In severe cases the 
disease evolves to CHF, cardiomegaly, arrhythmias, conduction block 
of the electrical stimulus, thromboembolic events, ischemic stroke and 
sudden death11,54. Among individuals who develop this clinical form of 
the disease, a significant group becomes candidate for the use of artificial 
heart devices, such as defibrillators and pacemakers, with CD being the 
major cause of the implantation of such devices53.
The presence of electrocardiographic changes is a fundamental 
element in the characterization of significant cardiac involvement in 
CD11. The electrocardiographic findings in this study are in agreement 
with the literature. ALMEIDA et al.3, when evaluating 61 elderly chagasic 
patients, found ECG abnormalities in 85.2%, the most prevalent of 
which were: ASDB (41.0%), RBBB (32.8%), VES (22.9 %) and CVR 
(11.5%). The most prevalent conduction disorder in the sample of the 
present study was the RBBB (41.0%), associated or not to ASDB, data 
also convergent with the literature. NETTO et al.44 also studied elderly 
patients and confirmed the RBBB as the most frequent alteration in 
the chagasic group. According to the Brazilian Consensus on CD11, 
electrocardiographic changes characteristic of CD include: RBBB with 
or without ASDB, VES, sinus bradycardia with a cardiac frequency lower 
than 40 bpm, AVB of 2nd degree or total, CVR, presence of EIA, sinus 
node dysfunction, AF and LBBB.
With respect to the existence of chronic diseases concomitant with 
CD, the high percentage (86.6%) of patients that reported at least one 
comorbidity associated with T. cruzi infection in this study was expected, 
since, according to the literature, the elderly have higher morbidity rates 
than other groups of patients61,64.
A similar result was found by ALVES et al.4, where the average 
number of comorbidities associated with CD by elderly patients was 
2.8 ± 1.8, the most prevalent of which were: SAH (56.7%), osteoporosis 
(23.3%), osteoarthritis (21.2%), dyslipidemia (20%), ischemic heart 
disease, diabetes mellitus and dyspepsia in equal proportions (10%), as 
well as CHF and hypothyroidism, which had an incidence of 7.78% each.
Statistics show that the main cause of morbidity and mortality among 
elderly Brazilians is cardiovascular diseases and the main ones include: 
CVA, CHF, coronary heart disease, hypertrophic cardiomyopathy, 
valvular disease (aortic stenosis and mitral valve disease), arrhythmia and 
SAH36,37,55,64. In a survey based on the analyses of data from the Ministry 
of Health, it was found that in Maringá - PR, between 1970 and 1990, 
there was a significant increase in the number of deaths associated with 
SAH (119%) and an increased risk of death associated with cardiovascular 
disease in both sexes as age advances42. In the present population, the 
most frequent cardiovascular diseases were SAH (67%), CHF (8.2%), 
ischemic heart disease (4.1%) and CVA (3.1%). It is important to note 
that hypertension and dyslipidemia, major comorbidities found in this 
study with prevalence rates of 67% and 31.9% among elderly patients 
with CD, are important factors for the development of ischemic heart 
disease and cerebrovascular disease4, 37.
Previous publications have shown that SAH is the most common 
cardiovascular disease in chagasic populations3,27,46,57 and that it has a 
higher prevalence in patients aged over 50 years, showing a cumulative 
effect between the two pathologies5,24. Greater myocardial damage was 
observed by GUARIENTO et al.20 in patients with this combination 
of diseases. They determined that more severe forms of heart disease 
occurred in chagasic patients suffering from SAH than in those who did 
not have SAH. Also, high levels of heart damage from SAH in elderly 
chagasic patients who died and underwent necropsy have been observed45.
There is still scarce data in the literature about concomitant 
hypertension and CD. Research related to this association is relevant due 
to the known presence of parasympathetic nervous system involvement in 
CD, which determines a higher sympathetic activity, leading to a probable 
influence on the genesis of hypertension in these patients25,26. Some 
authors23,24 point out trypanosomiasis pathophysiology as a contributing 
factor to high blood pressure, also indicating that 50% of individuals 
with this combination of pathologies are over 45 years old and already 
have CHF to some degree.
GURGEL et al.25, when correlating the frequency of SAH in chronic 
CD carriers with age, observed that the 225 chagasic and hypertensive 
patients had a median age distribution of 55 years with significant 
differences of hypertensive degree between age groups for both sexes 
(p < 0.001 for females and p < 0.05 for males). Higher levels of blood 
pressure were found in elderly chagasic patients, particularly females, 
showing the association of both diseases in advanced age groups.
Thus, it is plausible to suppose that there is a higher risk of death 
among aging chronic carriers of CD, and that this fact is associated 
with a higher incidence of cardiovascular disease (particularly the 
higher incidence of SAH)4. Moreover, it cannot be forgotten that the 
physiological changes resulting from the cardiovascular aging process 
contribute to the deterioration of cardiac function, leading to a functional 
decline33,40.
The cardiac complications resulting from the process of evolution of 
Chagas heart disease are important causes of hospitalization and increase 
mortality associated with clinical decompensation10. BOZELLI et al.7 
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studied the medical records of 95 patients diagnosed with CD treated at 
the University Hospital of Maringa (HUM). They observed that the mean 
age of patients treated in the inpatient service (61.2 years ± 12.8) was 
significantly higher than that of the outpatient unit (50.1 years ± 12.5). 
In most cases, hospitalization was assigned to the symptoms resulting 
from CHF. According to FRANÇA & ABREU17, the presence of these 
complications increases therapeutic costs, highlighting the importance 
of University Hospitals in providing a differentiated care to this group 
of patients.
The most commonly used therapeutic agents were consistent 
with the most prevalent clinical form of CD in the elderly population 
studied (cardiac form). The main drugs used were found to act in the 
cardiovascular function, as follows: diuretics (45.4%), ACEI (36.1%), 
α and β-blockers (21.6%) and anticoagulants (21.6%). The average of 
three medications per patient was expected, since the elderly, due to 
accumulation of chronic diseases, comprise the most medicalized group 
in society19.
Polypharmacy is an important issue among the geriatric population, 
given that the consequence of the wide use of drugs affects their clinical 
and economic context, impacting on patient safety56. Risks related to 
polypharmacy are higher in the older age group due to the physiological 
changes resulting from aging (eg.: reduced metabolic capacity of the 
liver and renal involvement), which lead to an increased incidence of 
adverse reactions and more serious repercussions which may increase 
morbidity and mortality1,8,56.
It can be concluded, therefore, that the chagasic elderly comprise a 
vulnerable group of patients that have an association between the risk 
of morbimortality for Chagas heart disease and the other comorbidities 
often present in this age group, as well as the risk of drug interactions 
due to polypharmacy. Since the growth of the chagasic population above 
60 years is a reality, this finding should draw the attention of health 
authorities to improve access to health services as well as the training 
of qualified professionals in the treatment and recognition of clinical 
differences inherent to this group of patients.
RESUMO
Perfil clínico e epidemiológico de pacientes idosos com doença 
de Chagas atendidos entre 2005-2013 por um serviço de atenção 
farmacêutica no estado do Ceará, nordeste do Brasil
Controlando-se a transmissão da doença de Chagas, surge o desafio 
de prestar assistência a milhões de pacientes infectados que chegam à 
velhice. Neste estudo, foram avaliados os registros socioeconômicos, 
demográficos e de comorbidades de todos os pacientes chagásicos idosos 
acompanhados no Serviço de Atenção Farmacêutica do Laboratório 
de Pesquisa em Doença de Chagas. As informações relacionadas à 
forma clínica da doença foram obtidas a partir de registros médicos 
disponibilizados pelo Hospital Universitário Walter Cantídio. O perfil 
da população estudada foi de: mulheres (50,5%); idade média de 67 
anos; aposentados (54,6%); casados (51,6%); alta taxa de analfabetismo 
(40,2%); e renda familiar de um salário mínimo (51,5%). As formas 
clínicas predominantes da doença de Chagas foram a cardíaca (65,3%) 
e a indeterminada (14,7%). As principais alterações eletrocardiográficas 
foram o bloqueio de ramo direito (41,0%), associado ou não ao bloqueio 
ântero superior esquerdo (27,4%). O número médio de comorbidades 
por paciente foi de 2,23 ± 1,54, sendo a hipertensão arterial sistêmica 
a principal encontrada (67,0%). Verificou-se que os idosos constituem 
grupo vulnerável de pacientes que associam o envelhecimento com as 
alterações cardíacas e/ou digestivas resultantes da evolução da doença 
de Chagas e outras comorbidades, o que exige atenção especial dos 
serviços de saúde para um atendimento médico e social mais adequado.
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